{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:36:14Z","timestamp":1787884574387,"version":"build-2784847793"},"reference-count":80,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[1998,5,1]],"date-time":"1998-05-01T00:00:00Z","timestamp":893980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,5,1]]},"abstract":"<jats:title>Abstarct<\/jats:title>\n                  <jats:p>Calcium channel blockers are becoming increasingly popular in veterinary medicine for the treatment of systemic hypertension, cardiac arrhythmias, and hypertrophic cardiomyopathy. Calcium is vital to many cellular functions and thus stringent regulation of intracellular calcium concentrations is required. Pharmacologic manipulation of the regulatory mechanisms has the potential to alter cellular function in all body systems. In human medicine, calcium channel blockers are being evaluated for, among other things, use in treating glaucoma, deep vein thrombosis, and pulmonary hypertension, in renal transplantation, and for prevention of reperfusion injury. The potentially beneficial effects of these drugs have often been overshadowed by adverse effects including hypotension, inappetence, bradycardia, conduction abnormalities, and decreased cardiac output. With the introduction of sustained- release formulations (diltiazem) and 2nd generation calcium channel blockers (amlodipine) many of these effects have been attenuated or eliminated. This paper will review the functions of calcium and the calcium channels as well as discussing the classes and current and potential uses of the various calcium channel blockers.<\/jats:p>","DOI":"10.1111\/j.1939-1676.1998.tb02107.x","type":"journal-article","created":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T16:00:02Z","timestamp":1268236802000},"page":"123-131","source":"Crossref","is-referenced-by-count":26,"title":["Calcium Channel Blockers in Veterinary Medicine"],"prefix":"10.1093","volume":"12","author":[{"given":"Kirsten L.","family":"Cooke","sequence":"first","affiliation":[{"name":"College of Veterinary Medicine, University of Florida Department of Small Animal Clinical Sciences, , Gainesville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patti S.","family":"Snyder","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, University of Florida Department of Small Animal Clinical Sciences, , Gainesville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[1998,5,1]]},"reference":[{"key":"2026020303354254200_b1","first-page":"429","article-title":"Conversion of atrial fibrillation in two dogs using verapamil and supportive therapy","volume":"21","author":"Johnson","year":"1985","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020303354254200_b2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1939-1676.1991.tb03134.x","article-title":"Evaluation of the calcium channel blocking agents diltiazem and verapamil for treatment of feline hypertrophic cardiomyopathy","volume":"5","author":"Bright","year":"1991","journal-title":"J Vet Intern Med"},{"key":"2026020303354254200_b3","first-page":"147","article-title":"Evaluation of the antihypertensive agent amlodipine besylate in normotensive cats and a cat with systemic hypertension","volume":"8","author":"Snyder","year":"1994","journal-title":"J Vet Intern Med"},{"key":"2026020303354254200_b4","first-page":"145","article-title":"Amlodipine besylate therapy in cats with systemic arterial hypertension secondary to chronic renal disease","volume":"8","author":"Henik","year":"1994","journal-title":"J Vet Intern Med"},{"key":"2026020303354254200_b5","first-page":"139","article-title":"Blinded clinical trial of amlodipine in cats with hypertension","volume":"11","author":"Snyder","year":"1997","journal-title":"J Vet Intern Med"},{"key":"2026020303354254200_b6","first-page":"57","volume-title":"Textbook of Medical Physiology","author":"Guyton","year":"1996"},{"key":"2026020303354254200_b7","first-page":"565","volume-title":"Textbook of Medical Physiology","author":"Guyton","year":"1996"},{"key":"2026020303354254200_b8","first-page":"219","volume-title":"Physiology of the Heart","author":"Katz","year":"1992","edition":"2nd"},{"key":"2026020303354254200_b9","doi-asserted-by":"crossref","first-page":"6F","DOI":"10.1016\/0002-9149(92)90182-X","article-title":"Molecular and cellular aspects of calcium channel antagonism","volume":"70","author":"Schwartz","year":"1992","journal-title":"Am J Cardiol"},{"key":"2026020303354254200_b10","first-page":"75","volume-title":"Cell Pathology","author":"Cheville","year":"1983"},{"key":"2026020303354254200_b11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0014-4827(87)90161-3","article-title":"Pathways of Ca2+ influx at the plasma membrane: Voltage-, receptor-, and second messenger-operated channels","volume":"171","author":"Meldolesi","year":"1987","journal-title":"Exp Cell Res"},{"key":"2026020303354254200_b12","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1139\/y90-224","article-title":"Calcium, calcium channels, and calcium channel antagonists","volume":"68","author":"Triggle","year":"1990","journal-title":"Can J Physiol Pharmacol"},{"key":"2026020303354254200_b13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.ph.51.030189.002055","article-title":"Classes of calcium channels in vertebrate cells","volume":"51","author":"Bean","year":"1989","journal-title":"Annu Rev Physiol"},{"key":"2026020303354254200_b14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1113\/jphysiol.1988.sp016916","article-title":"Contribution of two types of calcium current to the pacemaker potentials of rabbit sinoatrial node cells","volume":"359","author":"Hagiwara","year":"1988","journal-title":"J Physiol"},{"key":"2026020303354254200_b15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00005344-199601000-00021","article-title":"Mechanism of the antiischemic effect of mibefradil, a selective T calcium channel blocker in dogs: Comparison with amlidopone","volume":"27","author":"Roux","year":"1996","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026020303354254200_b16","first-page":"185","volume-title":"Cardiovascular Pharmacology and Therapeutics","author":"Aristizabal","year":"1994"},{"key":"2026020303354254200_b17","first-page":"50","volume-title":"Drugs for the Heart","author":"Opie","year":"1995","edition":"4th"},{"key":"2026020303354254200_b18","first-page":"548","volume-title":"Heart Disease: A Textbook of Cardiovascular Medicine","author":"Zipes","year":"1997","edition":"5th"},{"key":"2026020303354254200_b19","first-page":"613","volume-title":"Molecular Biology of the Cell","author":"Alberts","year":"1989"},{"key":"2026020303354254200_b20","first-page":"691","article-title":"Calcium channel blocking agents","volume":"17","author":"Pion","year":"1995","journal-title":"Compend Contin Educ Pract Vet"},{"key":"2026020303354254200_b21","first-page":"747","volume-title":"Cardiovascular Pharmacology and Therapeutics","author":"Singh","year":"1994"},{"key":"2026020303354254200_b22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/clc.4960150104","article-title":"Regression of left ventricular mass in systemic hypertension","volume":"15","author":"Georgiou","year":"1992","journal-title":"Clin Cardiol"},{"issue":"Suppl 4","key":"2026020303354254200_b23","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005344-199015004-00002","article-title":"The pharmacology of calcium antagonists: A review","volume":"15","author":"Struyker-Boudier","year":"1990","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026020303354254200_b24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0021-9150(85)90059-0","article-title":"The calcium antagonist nifedipine inhibits arterial smooth muscle cell proliferation","volume":"58","author":"Nilsson","year":"1985","journal-title":"Atherosclerosis"},{"key":"2026020303354254200_b25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0021-9150(88)90004-4","article-title":"Inhibitor effect of calcium antagonists on balloon catheter-induced arterial smooth muscle cell proliferation and lesion size","volume":"69","author":"Jackson","year":"1988","journal-title":"Atherosclerosis"},{"key":"2026020303354254200_b26","first-page":"H366","article-title":"Effects of verapamil and diltiazem on human platelet function","volume":"250","author":"Addonizio","year":"1986","journal-title":"Am J Physiol"},{"key":"2026020303354254200_b27","first-page":"435","volume-title":"Canine and Feline Cardiology","author":"Fox","year":"1988"},{"key":"2026020303354254200_b28","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0195-5616(91)50110-8","article-title":"Evidence for or against the efficacy of calcium channel blockers for management of hypertrophic cardiomyopathy in cats","volume":"21","author":"Bright","year":"1991","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2026020303354254200_b29","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0272-6386(87)80191-9","article-title":"Amlidopone therapy corrects renal abnormalities encountered in the hypertensive state","volume":"10","author":"Reams","year":"1987","journal-title":"Am J Kidney Dis"},{"key":"2026020303354254200_b30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF00265946","article-title":"Effects of amlodipine on renal haemodynamics in mild to moderate hypertensive patients. A randomized controlled study versus placebo","volume":"45","author":"Licata","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"key":"2026020303354254200_b31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1476-5381.1988.tb11532.x","article-title":"A study of the renal actions of amlodipine in the normotensive and spontaneously hypertensive rat","volume":"94","author":"Johns","year":"1988","journal-title":"Br J Pharmacol"},{"issue":"Suppl 6","key":"2026020303354254200_b32","first-page":"S394","article-title":"Acute, chronic and post withdrawal antihypertensive and renal effects of amlodipine in hypertensive patients","volume":"9","author":"Leonetti","year":"1991","journal-title":"J Hypertens"},{"issue":"Suppl 1","key":"2026020303354254200_b33","first-page":"S45","article-title":"Are there differences in the renal effects of calcium antagonists","volume":"10","author":"Leonetti","year":"1992","journal-title":"J Hypertens"},{"key":"2026020303354254200_b34","first-page":"584","article-title":"Effect of cyclosporine A on post ischemic acute renal failure in conscious dogs: Role of vasoactive renal hormones","volume":"20","author":"Neumayer","year":"1988","journal-title":"Transplant Proc"},{"key":"2026020303354254200_b35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/08860229209047658","article-title":"Acute cyclosporine A renal dysfunction in dogs reversed by calcium antagonists and antiplatelet agents","volume":"14","author":"Grekas","year":"1992","journal-title":"Renal Fail"},{"key":"2026020303354254200_b36","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/ki.1993.61","article-title":"Converting enzyme inhibitor versus calcium antagonist in cyclosporine-treated renal transplants","volume":"43","author":"Mourad","year":"1993","journal-title":"Kidney Int"},{"key":"2026020303354254200_b37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/01.HYP.25.1.77","article-title":"Hypertension after renal transplantation: Calcium channel or converting enzyme blockade","volume":"25","author":"van der Schaaf","year":"1995","journal-title":"Hypertension"},{"key":"2026020303354254200_b38","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/ndt\/7.8.791","article-title":"Pathophysiology of cyclosporine A nephrotoxicity: Experimental and clinical observations","volume":"7","author":"McNally","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"2026020303354254200_b39","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0002-9149(89)90961-2","article-title":"Inhibition by amlodipine of activity evoked in human coronary arteries by endothelin, prostaglandin F2\u03b1 and depolarization","volume":"64","author":"Godfraind","year":"1989","journal-title":"Am J Cardiol"},{"key":"2026020303354254200_b40","first-page":"S28","article-title":"Calcium channel blockers in organ transplantation: Important new therapeutic modalities","volume":"1","author":"Weir","year":"1990","journal-title":"J Am Soc Nephrol"},{"key":"2026020303354254200_b41","first-page":"F217","article-title":"Renal microvascular effects of endothelin","volume":"259","author":"Edwards","year":"1990","journal-title":"Am J Physiol"},{"key":"2026020303354254200_b42","doi-asserted-by":"crossref","first-page":"251S","DOI":"10.1093\/ajh\/6.7.251S","article-title":"Calcium antagonists and the kidney","volume":"6","author":"Epstein","year":"1993","journal-title":"Am J Hypertens"},{"key":"2026020303354254200_b43","first-page":"480","article-title":"Acute cyclosporine-induced renal vasoconstriction is mediated by endothelin\u20141","volume":"114","author":"Bloom","year":"1993","journal-title":"Surgery"},{"key":"2026020303354254200_b44","first-page":"1221","article-title":"Effects of amlodipine on renal hemodynamics","volume":"64","author":"Loutzenhiser","year":"1989","journal-title":"Am J Cardiol"},{"key":"2026020303354254200_b45","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.RES.78.4.643","article-title":"Inhibitory effects of TA-993, a new 1,5-benzothiazepine derivative on platelet aggregation","volume":"78","author":"Odawara","year":"1996","journal-title":"Circ Res"},{"key":"2026020303354254200_b46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5326\/15473317-32-1-11","article-title":"Comparison of the effects of diltiazem and aspirin on platelet aggregation on cats","volume":"32","author":"Behrend","year":"1996","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020303354254200_b47","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2460\/javma.1988.193.12.1525","article-title":"Verapamil administration for acute termination of supraventricular tachycardia in dogs","volume":"193","author":"Kittleson","year":"1988","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303354254200_b48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-3565(25)32901-0","article-title":"Myocardial disposition and cardiac pharmacodynamics of verapamil in the dog","volume":"220","author":"Keefe","year":"1982","journal-title":"J Pharmacol Exp Ther"},{"key":"2026020303354254200_b49","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0022-3565(25)30928-6","article-title":"The pharmacology of verapamil I: Elimination kinetics in dogs and correlation of plasma levels with effect on the electrocardiogram","volume":"202","author":"McAllister","year":"1977","journal-title":"J Pharmacol Exp Ther"},{"key":"2026020303354254200_b50","first-page":"89","article-title":"Clinical and experimental studies with verapamil in the dog. Proc 5th Bien Symp Vet Pharmacol Ther","author":"Hamlin","year":"1986"},{"key":"2026020303354254200_b51","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI112505","article-title":"Treatment of verapamil toxicity in intact dogs","volume":"77","author":"Gay","year":"1986","journal-title":"J Clin Invest"},{"key":"2026020303354254200_b52","first-page":"309","volume-title":"Canine and Feline Cardiology","author":"Muir","year":"1988"},{"key":"2026020303354254200_b53","first-page":"148","volume-title":"Veterinary Drug Handbook","author":"Plumb","year":"1991"},{"key":"2026020303354254200_b54","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/0002-9149(82)91251-6","article-title":"Verapamil and digoxin: Their respective effects on atrial fibrillation and their interaction","volume":"50","author":"Klein","year":"1982","journal-title":"Am J Cardiol"},{"key":"2026020303354254200_b55","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/clpt.1985.243","article-title":"Effects of verapamil, diltiazem, and nifedipine on plasma levels and renal excretion of digitoxin","volume":"38","author":"Kuhlmann","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"2026020303354254200_b56","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00005344-198305000-00021","article-title":"Relationship between plasma diltiazem and cardiovascular responses in conscious dogs","volume":"5","author":"Browne","year":"1983","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026020303354254200_b57","first-page":"759","article-title":"Clinical use of diltiazem for dogs in atrial fibrillation. Proc Am Coll Vet Intern Med","author":"Hamlin","year":"1988"},{"key":"2026020303354254200_b58","first-page":"1001","article-title":"Left ventricular function and failure\u2014Part II","volume":"16","author":"Kittleson","year":"1994","journal-title":"Compend Contin Educ Pract Vet"},{"key":"2026020303354254200_b59","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2460\/javma.1990.197.11.1475","article-title":"Sympathetic activation in dogs with congestive heart failure caused by chronic mitral valve disease and dilated cardiomyopathy","volume":"197","author":"Ware","year":"1990","journal-title":"J Am Vet Med Assoc"},{"key":"2026020303354254200_b60","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0002-9149(82)80006-4","article-title":"Pharmacokinetics of diltiazem in selected animal species and human beings","volume":"49","author":"Piepho","year":"1982","journal-title":"Am J Cardiol"},{"key":"2026020303354254200_b61","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0090-9556(25)07320-9","article-title":"Effects of propranolol on the disposition and negative dromotropic activity of diltiazem in the dog during multiple dosing","volume":"21","author":"Maskasame","year":"1993","journal-title":"Drug Metab Dispos"},{"key":"2026020303354254200_b62","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1939-1676.1996.tb02069.x","article-title":"Pharmacokinetic and pharmacodynamic properties of conventional and CD-formulated diltiazem in cats","volume":"10","author":"Johnson","year":"1996","journal-title":"J Vet Intern Med"},{"key":"2026020303354254200_b63","first-page":"684","volume-title":"Current Veterinary Therapy XI: Small Animal Practice","author":"Pion","year":"1992"},{"key":"2026020303354254200_b64","first-page":"161","volume-title":"Current Veterinary Therapy XII: Small Animal Practice","author":"Russell","year":"1995"},{"key":"2026020303354254200_b65","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/bdd.2510130706","article-title":"The effects of chronic oral diltiazem and cimetidine dosing on the pharmacokinetics and negative dromotropic action of intravenous and oral diltiazem in the dog","volume":"13","author":"Maskasame","year":"1992","journal-title":"Biopharm Drug Dispos"},{"key":"2026020303354254200_b66","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/0002-8703(89)90587-5","article-title":"Diltiazem attenuates the inotropic and peripheral vascular effects of cardiac glycosides","volume":"118","author":"Watford","year":"1989","journal-title":"Am Heart J"},{"key":"2026020303354254200_b67","first-page":"175","article-title":"Nifedipine: A temporizing therapeutic option for the treatment of megaesophagus in adult dogs","volume":"25","author":"Chandra","year":"1989","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020303354254200_b68","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0022-2828(08)80024-7","article-title":"Inhibition of cardiac L-type calcium channels by quaternary amlodipine: Implications for pharmacokinetics and access to dihydropyridine binding site","volume":"27","author":"Kwan","year":"1995","journal-title":"J Mol Cell Cardiol"},{"key":"2026020303354254200_b69","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/00005344-199423030-00016","article-title":"Pharmacokinetics of amlodipine and its occupancy of calcium antagonist receptors","volume":"23","author":"Yamada","year":"1994","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026020303354254200_b70","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2165\/00003495-199550030-00009","article-title":"Amlodipine: A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease","volume":"50","author":"Haria","year":"1995","journal-title":"Drugs"},{"key":"2026020303354254200_b71","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/0002-9149(89)90967-3","article-title":"Cardioprotective effects of amlodipine in the ischemic-reperfused heart","volume":"64","author":"Hoff","year":"1989","journal-title":"Am J Cardiol"},{"key":"2026020303354254200_b72","doi-asserted-by":"crossref","first-page":"2A","DOI":"10.1016\/0002-9149(94)90268-2","article-title":"Unique pharmacologic properties of amlodipine","volume":"73","author":"Burges","year":"1994","journal-title":"Am J Cardiol"},{"key":"2026020303354254200_b73","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/0002-9149(89)90966-1","article-title":"Effects of amlodipine on myocardial ischemia-reperfusion injury in dogs","volume":"64","author":"Gross","year":"1989","journal-title":"Am J Cardiol"},{"key":"2026020303354254200_b74","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0002-9149(89)90963-6","article-title":"Hemodynamic and electrophysiologic effects of amlodipine, a new calcium channel Mocker","volume":"64","author":"Dunlap","year":"1989","journal-title":"Am J Cardiol"},{"key":"2026020303354254200_b75","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0002-9149(89)90965-X","article-title":"Protection of regional mechanics and mitochondrial oxidative phosphorylation by amlodipine in transiently ischemic myocardium","volume":"64","author":"Dunlap","year":"1989","journal-title":"Am J Cardiol"},{"issue":"Suppl 7","key":"2026020303354254200_b76","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/00005344-198812007-00012","article-title":"The metabolism and pharmacokinetics of amlodipine in humans and animals","volume":"12","author":"Stopher","year":"1988","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026020303354254200_b77","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2165\/00003088-199222010-00003","article-title":"Clinical pharmacokinetics of amlodipine","volume":"22","author":"Meredith","year":"1992","journal-title":"Clin Pharmacokinet"},{"key":"2026020303354254200_b78","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/0002-8703(89)90834-X","article-title":"The pharmacokinetic profile of amlodipine","volume":"118","author":"Abernethy","year":"1989","journal-title":"Am Heart J"},{"key":"2026020303354254200_b79","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2165\/00003088-199222060-00002","article-title":"Clinical pharmacokinetics of calcium antagonists: An update","volume":"22","author":"Kelly","year":"1992","journal-title":"Clin Pharmacokinet"},{"key":"2026020303354254200_b80","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1939-1676.1998.tb02111.x","article-title":"Amlodipine: A randomized, blinded clinical trial in 9 cats with systemic hypertension","volume":"12","author":"Snyder","year":"1998","journal-title":"J Vet Intern Med"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1939-1676.1998.tb02107.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/12\/3\/123\/66686925\/j.1939-1676.1998.tb02107.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/12\/3\/123\/66686925\/j.1939-1676.1998.tb02107.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T08:36:12Z","timestamp":1770107772000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/12\/3\/123\/8452345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5,1]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,5,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1939-1676.1998.tb02107.x","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1998,5]]},"published":{"date-parts":[[1998,5,1]]}}}